Skip to main content
. 2009 Jun 29;114(12):2393–2400. doi: 10.1182/blood-2009-03-211797

Figure 3.

Figure 3

Time to leukemic transformation of patients randomized to the SC alone (arm A, n = 57) and EPO/G-CSF (arm B, n = 53) arms. No statistically significant difference in time to transformation between these 2 groups of patients was demonstrated (P = .83).